• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Evaluation of rapid influenza diagnostic tests for influenza A and B in the tropics

tetano

Editor, Senior Moderator
J Med Virol. 2019 Apr 29. doi: 10.1002/jmv.25495. [Epub ahead of print]
[h=1]Evaluation of rapid influenza diagnostic tests for influenza A and B in the tropics.[/h] Chong YM[SUP]1[/SUP], Tan XH[SUP]1[/SUP], Hooi PS[SUP]2[/SUP], Lee LM[SUP]2[/SUP], Sam IC[SUP]1,[/SUP][SUP]2[/SUP], Chan YF[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Rapid diagnosis of influenza is important for early treatment and institution of control measures. In developing tropical countries such as Malaysia, influenza occurs all year round, but molecular assays and conventional techniques (such as immunofluorescence and culture) for diagnosis are not widely available. Rapid influenza diagnostic tests (RIDTs) may be useful in this setting. A total of 552 fresh respiratory specimens were assessed from patients with respiratory symptoms at a teaching hospital in Kuala Lumpur, Malaysia from November 2017 to March 2018. Two digital immunoassays (DIAs), STANDARD F Influenza A/B Fluorescence Immunoassay (STANDARD F) and Sofia Influenza A+B Fluorescence Immunoassay (Sofia) and one conventional RIDT (immunochromatographic assay), SD Bioline Influenza Ag A/B/A(H1N1) Pandemic rapid test kit (SD Bioline) were evaluated in comparison to a WHO-recommended RT-qPCR assay. Of the 552 samples, influenza A virus was detected in 47 (8.5%) and influenza B virus in 7 (1.3%). The digital immunoassays STANDARD F and Sofia had significantly higher overall sensitivity rates (71.7% and 70.6%, respectively) than the conventional RIDT SD Bioline and immunofluorescence/viral culture (55.8% and 52.8%, respectively). Sensitivity rates were higher for influenza A than influenza B, and specificity rates were uniformly high, ranging from 98-100%. Digital readout RIDTs can be used in tropical settings with year-round influenza if PCR is unavailable. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.


[h=4]KEYWORDS:[/h] Immunologic techniques; Influenza virus; Pathogenesis; Research and Analysis Methods; Respiratory tract; Virus classification

PMID: 31032971 DOI: 10.1002/jmv.25495
 
Back
Top Bottom